The intricacies of Medtech regulation in the US FDA System

26 August 2020

 

On 7 August 2020, the Longitude Prize hosted a virtual workshop as part of the Longitude Prize Sprint Programme. This workshop drew upon insights from experts in Medtech regulation and addressed the nuances of regulation in different geographies to guide Medtech companies in their product development strategies.

Dr. Sally Hojvat, former Director of the Division of Microbiology at FDA discusses the intricacies of Medtech regulation in the US FDA System.